1. Market Research
  2. > Healthcare
  3. > Health Services Market Trends

Integra LifeSciences Holdings Corporation - Strategy and SWOT Report

  • December 2015
  • 31 pages
  • MarketLine
Report ID: 3696408

Summary

Table of Contents

Search Inside

Introduction

Integra LifeSciences Holdings Corporation - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Features:

- Detailed information on Integra LifeSciences Holdings Corporation required for business and competitor intelligence needs

- A study of the major internal and external factors affecting Integra LifeSciences Holdings Corporation in the form of a SWOT analysis

- An in-depth view of the business model of Integra LifeSciences Holdings Corporation including a breakdown and examination of key business segments

- Intelligence on Integra LifeSciences Holdings Corporation’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

- News about Integra LifeSciences Holdings Corporation, such as business expansion, restructuring, and contract wins

- Large number of easy-to-grasp charts and graphs that present important data and key trends

Highlights:

Integra LifeSciences Holdings Corporation (Integra or 'the company') is a leading provider of regenerative technologies, specialty surgical solutions, orthopedics and tissue technologies. It operates in the US, Europe and other regions of the world. It is headquartered in Plainsboro, New Jersey, and employed about 3,400 people as on December 31, 2014. The company recorded revenues of $928.3 million during the financial year ended December 2014 (FY2014), an increase of 11% over FY2013. The operating profit of the company was $65.5 million in FY2014, as compared with an operating loss of $10.2 million in FY2013. The net profit of the company was $34 million in FY2014, as compared with a net loss of $21.1 million in FY2013.

Reasons to Purchase:

- Gain understanding of Integra LifeSciences Holdings Corporation and the factors that influence its strategies

- Track strategic initiatives of the company and latest corporate news and actions

- Assess Integra LifeSciences Holdings Corporation as a prospective partner, vendor or supplier

- Support sales activities by understanding your customers' businesses better

- Stay up to date on Integra LifeSciences Holdings Corporation’s business structure, strategy and prospects

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Veronica helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Integrin Beta 1 (Fibronectin Receptor Subunit Beta or Glycoprotein Iia or VLA 4 Subunit Beta or CD29 or ITGB1) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Integrin Beta 1 (Fibronectin Receptor Subunit Beta or Glycoprotein Iia or VLA 4 Subunit Beta or CD29 or ITGB1) - Pipeline Review, H1 2017 Summary According to the recently published report 'Integrin Beta ...

Scar - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • March 2017
  • by Global Markets Direct

Scar - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Scar - Pipeline Review, H1 2017, provides an overview of the Scar (Dermatology) ...

Bone Marrow Transplant Rejection - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • March 2017
  • by Global Markets Direct

Bone Marrow Transplant Rejection - Pipeline Review, H1 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Bone Marrow Transplant Rejection - Pipeline Review, ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.